Bio Works (Sweden) Buy Hold or Sell Recommendation

BIOWKS Stock  SEK 1.55  0.13  9.15%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Bio Works Technologies AB is 'Hold'. Macroaxis provides Bio Works buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOWKS positions.
  
Check out Bio Works Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Bio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bio Works Technologies AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Execute Bio Works Buy or Sell Advice

The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Works Technologies AB. Macroaxis does not own or have any residual interests in Bio Works Technologies AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio Works' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bio WorksBuy Bio Works
Hold

Market Performance

SolidDetails

Volatility

DangerousDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

About AverageDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Bio Works Technologies AB has a Risk Adjusted Performance of 0.1764, Jensen Alpha of 1.01, Total Risk Alpha of 1.58, Sortino Ratio of 0.2444 and Treynor Ratio of 1.69
We provide trade advice to complement the prevailing expert consensus on Bio Works Technologies. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Bio Works is not overpriced, please confirm all Bio Works Technologies fundamentals, including its cash per share, and the relationship between the revenue and target price .

Bio Works Trading Alerts and Improvement Suggestions

Bio Works is way too risky over 90 days horizon
Bio Works may become a speculative penny stock
Bio Works appears to be risky and price may revert if volatility continues
The company reported the revenue of 21.91 M. Net Loss for the year was (12.94 M) with profit before overhead, payroll, taxes, and interest of 53.01 M.
Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 55.0% of the company shares are held by company insiders

Bio Works Returns Distribution Density

The distribution of Bio Works' historical returns is an attempt to chart the uncertainty of Bio Works' future price movements. The chart of the probability distribution of Bio Works daily returns describes the distribution of returns around its average expected value. We use Bio Works Technologies AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio Works returns is essential to provide solid investment advice for Bio Works.
Mean Return
0.96
Value At Risk
-5.95
Potential Upside
9.52
Standard Deviation
4.98
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio Works historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Bio Works Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Works or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Works' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
1.01
β
Beta against Dow Jones0.56
σ
Overall volatility
5.22
Ir
Information ratio 0.21

Bio Works Volatility Alert

Bio Works Technologies AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Works' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Works' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Bio Works Fundamentals Vs Peers

Comparing Bio Works' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Works' direct or indirect competition across all of the common fundamentals between Bio Works and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Works or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Works' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Bio Works to competition
FundamentalsBio WorksPeer Average
Return On Equity-0.66-0.31
Return On Asset-0.35-0.14
Profit Margin(1.31) %(1.27) %
Operating Margin(1.27) %(5.51) %
Current Valuation635.01 M16.62 B
Shares Outstanding34.87 M571.82 M
Shares Owned By Insiders54.85 %10.09 %
Shares Owned By Institutions5.59 %39.21 %
Price To Book8.03 X9.51 X
Price To Sales19.71 X11.42 X
Revenue21.91 M9.43 B
Gross Profit53.01 M27.38 B
EBITDA(8.6 M)3.9 B
Net Income(12.94 M)570.98 M
Cash And Equivalents46.35 M2.7 B
Cash Per Share2.40 X5.01 X
Current Ratio9.14 X2.16 X
Book Value Per Share2.55 X1.93 K
Cash Flow From Operations(13.37 M)971.22 M
Earnings Per Share(0.41) X3.12 X
Target Price27.0
Number Of Employees3618.84 K
Beta0.99-0.15
Market Capitalization718.4 M19.03 B
Total Asset120.86 M29.47 B
Net Asset120.86 M

Bio Works Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Bio Works Buy or Sell Advice

When is the right time to buy or sell Bio Works Technologies AB? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Bio Works in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bio Stock

Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.